1. Potential pancreatic risks with GLP-1-based therapies for T2DM

   Non-clinical study 13 April 2013 Pages: 1 - 1

2. Ontario patients informed of chemotherapy underdosing

   Media release 13 April 2013 Pages: 2 - 2

3. Relpax contraindications underscored after CV events

   News item 13 April 2013 Pages: 2 - 2

4. Risk of bleeding with dabigatran not higher than with warfarin

   Review 13 April 2013 Pages: 2 - 2

5. Second look at trial data confirms niacin's link with unexpected AEs

   Media release 13 April 2013 Pages: 3 - 3

6. Fluvax: clearer labelling aims to prevent paediatric use

   News item 13 April 2013 Pages: 3 - 3

7. TGA aims to stimulate more ADR reporting from GPs, consumers

   News item 13 April 2013 Pages: 3 - 3

8. BMJ & MHRA launch pharmacovigilance learning module

   Media release 13 April 2013 Pages: 3 - 3

9. EMA reviews benefits, risks of flupirtine

   News item 13 April 2013 Pages: 3 - 3

10. Pulmonary antihypertensives in paeds, previously unreported AEs

    Review 13 April 2013 Pages: 4 - 4

11. Atazanavir cheaper and better tolerated than darunavir

    Clinical study 13 April 2013 Pages: 4 - 4

12. Increased risk of VTE with glucocorticoids in Denmark

    Epidemiology population study 13 April 2013 Pages: 4 - 4

13. Acitretin

    Case report 13 April 2013 Pages: 5 - 5

14. Adalimumab

    Case report 13 April 2013 Pages: 5 - 5

15. Adalimumab

    Case report 13 April 2013 Pages: 5 - 5

16. Adalimumab

    Case report 13 April 2013 Pages: 5 - 5

17. Adalimumab, azathioprine, prednisone

    Case report 13 April 2013 Pages: 5 - 5

18. Adenosine

    Case report 13 April 2013 Pages: 6 - 6

19. Amiodarone

    Case report 13 April 2013 Pages: 6 - 6

20. Amikacin/clarithromycin/ethambutol/moxifloxacin

    Case report 13 April 2013 Pages: 6 - 6

21. Amlodipine

    Case report 13 April 2013 Pages: 7 - 7

22. Amlodipine/butalbital overdose

    Case report 13 April 2013 Pages: 7 - 7

23. Amisulpride

    Case report 13 April 2013 Pages: 7 - 7

24. Amisulpride

    Case report 13 April 2013 Pages: 7 - 7

25. Anastrozole

    Case report 13 April 2013 Pages: 7 - 7

26. Antibacterials/warfarin

    Case report 13 April 2013 Pages: 8 - 8

27. Antineoplastics

    Case report 13 April 2013 Pages: 8 - 8

28. Armodafinil

    Case report 13 April 2013 Pages: 8 - 8

29. Antineoplastics

    Case report 13 April 2013 Pages: 8 - 8

30. BCG

    Case report 13 April 2013 Pages: 9 - 9

31. Aspirin/perindopril

    Case report 13 April 2013 Pages: 9 - 9

32. Bevacizumab

    Case report 13 April 2013 Pages: 9 - 9

33. Aspirin/clopidogrel

    Case report 13 April 2013 Pages: 9 - 9

34. Bevacizumab

    Case report 13 April 2013 Pages: 10 - 10

35. Bevacizumab

    Case report 13 April 2013 Pages: 10 - 10

36. Bevacizumab

    Case report 13 April 2013 Pages: 10 - 10

37. Bevacizumab/fluorouracil

    Case report 13 April 2013 Pages: 11 - 11

38. Bromazepam overdose

    Case report 13 April 2013 Pages: 11 - 11

39. Capecitabine/oxaliplatin

    Case report 13 April 2013 Pages: 11 - 11

40. Bevacizumab/antineoplastics

    Case report 13 April 2013 Pages: 11 - 11

41. Bupropion overdose

    Case report 13 April 2013 Pages: 11 - 11

42. Carbamazepine

    Case report 13 April 2013 Pages: 12 - 12

43. Carbamazepine/clonazepam/phenytoin

    Case report 13 April 2013 Pages: 12 - 12

44. Carbimazole

    Case report 13 April 2013 Pages: 12 - 12

45. Carboplatin/etoposide

    Case report 13 April 2013 Pages: 12 - 12

46. Carmustine

    Case report 13 April 2013 Pages: 13 - 13

47. Cetuximab

    Case report 13 April 2013 Pages: 13 - 13

48. Carmustine

    Case report 13 April 2013 Pages: 13 - 13

49. Ceftriaxone

    Case report 13 April 2013 Pages: 13 - 13

50. Cetuximab

    Case report 13 April 2013 Pages: 13 - 13